Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors

HIGHLIGHTS

• who: Rebekka Mispelbaum from the Laval University, Canada have published the research work: Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors, in the Journal: (JOURNAL)
• what: The aim of this study was to approach the question whether RBC transfusions impact outcome of IT in cancer patients. All variables included in this analysis had u22645% missing. The authors demonstrate that the concomitant administration of RBC concentrates negatively influences the response rate to IT.
• how: The authors conducted a retrolective clinical study of patients treated with IT for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.